Complications following an unnecessary peri-operative plasma transfusion and literature review

por Raval, Jay S., Waters, Jonathan H., Triulzi, Darrell J., Yazer, Mark H.
Publicado 2012

Complications following an unnecessary peri-operative plasma transfusion and literature review

por Raval, Jay S., Waters, Jonathan H., Triulzi, Darrell J., Yazer, Mark H.
Publicado 2014

Contemporary issues in transfusion medicine informatics

por Sharma, Gaurav, Parwani, Anil V., Raval, Jay S., Triulzi, Darrell J., Benjamin, Richard J., Pantanowitz, Liron
Publicado 2011

Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States

por Bell, Christopher E., Botteman, Marc F., Gao, Xin, Weissfeld, Joel L., Postma, Maarten J., Pashos, Chris L., Triulzi, Darrell, Staginnus, Ulf
Publicado 2003

Massive Transfusion Protocol Activation Does Not Result in Preferential Use of Older Red Blood Cells

por McDaniel, Lauren M., Triulzi, Darrell J., Cramer, James, Zuckerbraun, Brian S., Sperry, Jason L., Peitzman, Andrew B., Raval, Jay S., Neal, Matthew D.
Publicado 2014

Increased alloreactive and autoreactive antihuman leucocyte antigen antibodies associated with systemic lupus erythematosus and rheumatoid arthritis

por Jackman, Rachael P, Cruz, Giovanna I, Nititham, Joanne, Triulzi, Darrell J, Barcellos, Lisa F, Criswell, Lindsey A, Norris, Philip J, Busch, Michael P
Publicado 2018

Sex-specific genetic modifiers identified susceptibility of cold stored red blood cells to osmotic hemolysis

por Fang, Fang, Hazegh, Kelsey, Mast, Alan E., Triulzi, Darrell J., Spencer, Bryan R., Gladwin, Mark T., Busch, Michael P., Kanias, Tamir, Page, Grier P.
Publicado 2022

TEG-based transfusion protocol is associated with decreased blood product use without increased risk of hemoperitoneum

por Bromfield, Brittany, Tellez, Roberto, Hughes, Dempsey L., Brown, Rebecca, Andrzejewski, Margaret, Bawa, Aditi, Lin, Fei-Pi, Tublin, Mitchell, Triulzi, Darrell, Ganoza, Armando, Duarte-Rojo, Andres
Publicado 2023

Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a “humanized” G6PD A- mouse model

por Zuchelkowski, Benjamin E., Wang, Ling, Gingras, Sebastien, Xu, Qinzi, Yang, Minying, Triulzi, Darrell, Page, Grier P., Gordeuk, Victor R., Kim-Shapiro, Daniel B., Lee, Janet S., Gladwin, Mark T.
Publicado 2020

Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia

por Ilich, Anton, Gernsheimer, Terry B., Triulzi, Darrell J., Herren, Heather, Brown, Siobhan P., Holle, Lori A., Lucas, Andrew T., de Laat, Bas, El Kassar, Nahed, Wolberg, Alisa S., May, Susanne, Key, Nigel S.
Publicado 2022

Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial

por Gernsheimer, Terry B., Brown, Siobhan P., Triulzi, Darrell J., Key, Nigel S., El Kassar, Nahed, Herren, Heather, Poston, Jacqueline N., Boyiadzis, Michael, Reeves, Brandi N., Selukar, Subodh, Pagano, Monica B., Emerson, Scott, May, Susanne
Publicado 2022

Sickle Cell Trait Increases Red Blood Cell Storage Hemolysis and Post-Transfusion Clearance in Mice

por Osei-Hwedieh, David O., Kanias, Tamir, Croix, Claudette St., Jessup, Morgan, Xiong, Zeyu, Sinchar, Derek, Franks, Jonathan, Xu, Qinzi, M. Novelli, Enrico, Sertorio, Jonas T., Potoka, Karin, Binder, Robert J., Basu, Swati, Belanger, Andrea M., Kim-Shapiro, Daniel B., Triulzi, Darrell, Lee, Janet S., Gladwin, Mark T.
Publicado 2016

Mother−child histocompatibility and risk of rheumatoid arthritis and systemic lupus erythematosus among mothers

por Cruz, Giovanna I., Shao, Xiaorong, Quach, Hong, Quach, Diana, Ho, Kimberly A., Sterba, Kirsten, Noble, Janelle A., Patsopoulos, Nikolaos A., Busch, Michael P., Triulzi, Darrell J., Ladas, Nektarios, Blasczyk, Rainer, Wong, Wendy S. W., Solomon, Benjamin D., Niederhuber, John E., Criswell, Lindsey A., Barcellos, Lisa F.
Publicado 2019

Early Convalescent Plasma for High-Risk Outpatients with Covid-19

por Korley, Frederick K., Durkalski-Mauldin, Valerie, Yeatts, Sharon D., Schulman, Kevin, Davenport, Robertson D., Dumont, Larry J., El Kassar, Nahed, Foster, Lydia D., Hah, Jennifer M., Jaiswal, Siddartha, Kaplan, Alesia, Lowell, Ezekiel, McDyer, John F., Quinn, James, Triulzi, Darrell J., Van Huysen, Carol, Stevenson, Valerie L.W., Yadav, Kabir, Jones, Christopher W., Kea, Bory, Burnett, Aaron, Reynolds, Joshua C., Greineder, Colin F., Haas, Nathan L., Beiser, David G., Silbergleit, Robert, Barsan, William, Callaway, Clifton W.
Publicado 2021

CD4(+) T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1–Dependent

por Popescu, Iulia, Snyder, Mark E., Iasella, Carlo J., Hannan, Stefanie J., Koshy, Ritchie, Burke, Robin, Das, Antu, Brown, Mark J., Lyons, Emily J., Lieber, Sophia C., Chen, Xiaoping, Sembrat, John C., Bhatt, Payal, Deng, Evan, An, Xiaojing, Linstrum, Kelsey, Kitsios, Georgios, Konstantinidis, Ioannis, Saul, Melissa, Kass, Daniel J., Alder, Jonathan K., Chen, Bill B., Lendermon, Elizabeth A., Kilaru, Silpa, Johnson, Bruce, Pilewski, Joseph M., Kiss, Joseph E., Wells, Alan H., Morris, Alison, McVerry, Bryan J., McMahon, Deborah K., Triulzi, Darrell J., Chen, Kong, Sanchez, Pablo G., McDyer, John F.
Publicado 2022